On February 20, 2019 Veracyte, Inc. (Nasdaq: VCYT) reported that members of its management team will be participating in two upcoming investor conferences (Press release, Veracyte, FEB 20, 2019, View Source [SID1234533489]). Executives from the company will be meeting with investors at the BTIG MedTech, Life Science & Diagnostic Tools Conference 2019 on Wednesday, February 27, 2019, in Snowbird, Utah. There will not be a webcasted presentation.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Bonnie H. Anderson, chairman and chief executive officer, is scheduled to present at the 8th Annual SVB Leerink Global Healthcare Conference in New York City on Friday, March 1, 2019 at 9:00 a.m. EST. A live audio webcast of the company’s presentation will be available by visiting Veracyte’s website at View Source A replay of the webcast will be available for 90 days following the conclusion of the live presentation broadcast.